Answers are grounded in this paper and cite their sources.
The simultaneous occurrence of multiple myeloma (MM) and chronic myeloid leukemia (CML) is an extremely rare event that has been reported in only eight cases in the literature. We report here on only the third case of the development of MM in a patient with CML on treatment with imatinib mesylate, and to our knowledge, this is the first case in a patient who received imatinib as first-line treatment.
No takes yet. Share an insight, caveat, or question.
Michael et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: